+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • September 2021
  • Region: Global
  • TechNavio
  • ID: 5005574
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the pharmaceutical contract research and manufacturing (CRAM) market and it is poised to grow by $96.18 bn during 2021-2025, decelerating at a CAGR of over 10% during the forecast period. The report on the pharmaceutical contract research and manufacturing (CRAM) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the availability of cost-efficient resources in emerging markets and the growing need to focus on core competencies.

The pharmaceutical contract research and manufacturing (CRAM) market analysis includes the service segment and geographic landscape.

The pharmaceutical contract research and manufacturing (CRAM) market is segmented as below:


By Service

  • CMO
  • CRO

By Geographical Landscape

  • North America
  • Asia
  • Europe
  • ROW

This study identifies strong research funding as one of the prime reasons driving the pharmaceutical contract research and manufacturing (CRAM) market growth during the next few years. Also, strong research funding will lead to sizable demand in the market.

The report on the pharmaceutical contract research and manufacturing (CRAM) market covers the following areas:

  • Pharmaceutical contract research and manufacturing (CRAM) market sizing
  • Pharmaceutical contract research and manufacturing (CRAM) market forecast
  • Pharmaceutical contract research and manufacturing (CRAM) market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical contract research and manufacturing (CRAM) market vendors that include Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddys Laboratories Ltd., Icon Plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., and Thermo Fisher Scientific Inc. Also, the pharmaceutical contract research and manufacturing (CRAM) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Service

  • Market segments
  • Comparison by Service
  • CMO - Market size and forecast 2020-2025
  • CRO - Market size and forecast 2020-2025
  • Market opportunity by Service

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • Dr. Reddys Laboratories Ltd.
  • Icon Plc
  • IQVIA Holdings Inc.
  • Laboratory Corp. of America Holdings
  • Lonza Group Ltd.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ billion)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Service - Market share 2020-2025 (%)
  • Comparison by Service
  • CMO - Market size and forecast 2020-2025 ($ billion)
  • CMO - Year-over-year growth 2020-2025 (%)
  • CRO - Market size and forecast 2020-2025 ($ billion)
  • CRO - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Service
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ billion)
  • North America - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ billion)
  • Asia - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ billion)
  • Europe - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ billion)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ billion)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Almac Group Ltd. - Overview
  • Almac Group Ltd. - Product and service
  • Almac Group Ltd. - Key offerings
  • Almac Group Ltd. - Key customers
  • Almac Group Ltd. - Segment focus
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Business segments
  • Boehringer Ingelheim International GmbH - Key offerings
  • Boehringer Ingelheim International GmbH - Key customers
  • Boehringer Ingelheim International GmbH - Segment focus
  • Cadila Healthcare Ltd. - Overview
  • Cadila Healthcare Ltd. - Business segments
  • Cadila Healthcare Ltd. - Key offerings
  • Cadila Healthcare Ltd. - Key customers
  • Cadila Healthcare Ltd. - Segment focus
  • Catalent Inc. - Overview
  • Catalent Inc. - Business segments
  • Catalent Inc. - Key offerings
  • Catalent Inc. - Key customers
  • Catalent Inc. - Segment focus
  • Dr. Reddys Laboratories Ltd. - Overview
  • Dr. Reddys Laboratories Ltd. - Business segments
  • Dr. Reddys Laboratories Ltd. - Key offerings
  • Dr. Reddys Laboratories Ltd. - Key customers
  • Dr. Reddys Laboratories Ltd. - Segment focus
  • Icon Plc - Overview
  • Icon Plc - Product and service
  • Icon Plc - Key offerings
  • Icon Plc - Key customers
  • Icon Plc - Segment focus
  • IQVIA Holdings Inc. - Overview
  • IQVIA Holdings Inc. - Business segments
  • IQVIA Holdings Inc. - Key offerings
  • IQVIA Holdings Inc. - Key customers
  • IQVIA Holdings Inc. - Segment focus
  • Laboratory Corp. of America Holdings - Overview
  • Laboratory Corp. of America Holdings - Business segments
  • Laboratory Corp. of America Holdings - Key offerings
  • Laboratory Corp. of America Holdings - Key customers
  • Laboratory Corp. of America Holdings - Segment focus
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Product and service
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Key customers
  • Lonza Group Ltd. - Segment focus
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Key customers
  • Thermo Fisher Scientific Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global pharmaceutical contract research and manufacturing (cram) market: Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddys Laboratories Ltd., Icon Plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is strong research funding.`

According to the report, one of the major drivers for this market is the availability of cost-efficient resources in emerging markets.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • Dr. Reddys Laboratories Ltd.
  • Icon Plc
  • IQVIA Holdings Inc.
  • Laboratory Corp. of America Holdings
  • Lonza Group Ltd.
  • Thermo Fisher Scientific Inc.